help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Biophysical Journal 70: 1700-1708 (1996)
© 1996 the Biophysical Society

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D W
Right arrow Articles by Bennett, P B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D W
Right arrow Articles by Bennett, P B

Distinct local anesthetic affinities in Na+ channel subtypes.

D W Wang, L Nie, A L George, Jr and P B Bennett

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA.

ABSTRACT

Lidocaine is a widely used local anesthetic and antiarrhythmic drug that is believed to exert its clinically important action by blocking voltage-gated Na+ channels. Studies of Na+ channels from different species and tissues and the complexity of the drug-channel interaction create difficulty in understanding whether there are Na+ channel isoform specific differences in the affinity for lidocaine. Clinical usage suggests that lidocaine selectively targets cardiac Na+ channels because it is effective for the treatment of arrhythmias with few side effects on muscle or neuronal channels except at higher concentrations. One possibility for this selectivity is an intrinsically higher drug-binding affinity of the cardiac isoform. Alternatively, lidocaine may appear cardioselective because of preferential interactions with the inactivated state of the Na+ channel, which is occupied much longer in cardiac cells. Recombinant skeletal muscle (hSkM1) and cardiac sodium channels (hH1) were studied under identical conditions, with a whole-cell voltage clamp used to distinguish the mechanisms of lidocaine block. Tonic block at high concentrations of lidocaine (0.1 mM) was greater in hH1 than in hSkM1. This was also true for use-dependent block, for which 25-microM lidocaine produced an inhibition in hH1 equivalent to 0.1 mM in the skeletal muscle isoform. Pulse protocols optimized to explore inactivated-state block revealed that hSkM1 was five to eight times less sensitive to block by lidocaine than was hH1. The results also indicate that relatively more open-state block occurs in hSkM1. Thus, the cardiac sodium channel is intrinsically more sensitive to inhibition by lidocaine.




This article has been cited by other articles:


Home page
 J. Physiol.Home page
J.-F. Desaphy, A. D. E. Luca, M. P. Didonna, A. L. George Jr, and D. C. Camerino
Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block
J. Physiol., January 15, 2004; 554(2): 321 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. De Luca, S. Talon, M. De Bellis, J.-F. Desaphy, G. Lentini, F. Corbo, A. Scilimati, C. Franchini, V. Tortorella, and D. C. Camerino
Optimal Requirements for High Affinity and Use-Dependent Block of Skeletal Muscle Sodium Channel by N-Benzyl Analogs of Tocainide-Like Compounds
Mol. Pharmacol., October 1, 2003; 64(4): 932 - 945.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Hilber, W. Sandtner, O. Kudlacek, B. Schreiner, I. Glaaser, W. Schutz, H. A. Fozzard, S. C. Dudley, and H. Todt
Interaction between Fast and Ultra-slow Inactivation in the Voltage-gated Sodium Channel. DOES THE INACTIVATION GATE STABILIZE THE CHANNEL STRUCTURE?
J. Biol. Chem., September 27, 2002; 277(40): 37105 - 37115.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. G. Mujtaba, S.-Y. Wang, and G. K. Wang
Prenylamine Block of Nav1.5 Channel is Mediated via a Receptor Distinct from That of Local Anesthetics
Mol. Pharmacol., August 1, 2002; 62(2): 415 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
R. A. Li, I. L. Ennis, G. F. Tomaselli, and E. Marban
Structural Basis of Differences in Isoform-Specific Gating and Lidocaine Block between Cardiac and Skeletal Muscle Sodium Channels
Mol. Pharmacol., January 1, 2002; 61(1): 136 - 141.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J.-F. Desaphy, A. De Luca, P. Tortorella, D. De Vito, A. L. George Jr., and D. Conte Camerino
Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative
Neurology, November 27, 2001; 57(10): 1849 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. De Luca, F. Natuzzi, J.-F. Desaphy, G. Loni, G. Lentini, C. Franchini, V. Tortorella, and D. C. Camerino
Molecular Determinants of Mexiletine Structure for Potent and Use-Dependent Block of Skeletal Muscle Sodium Channels
Mol. Pharmacol., February 1, 2000; 57(2): 268 - 277.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
T. Weiser, Y. Qu, W. A. Catterall, and T. Scheuer
Differential Interaction of R-Mexiletine with the Local Anesthetic Receptor Site on Brain and Heart Sodium Channel alpha -Subunits
Mol. Pharmacol., December 1, 1999; 56(6): 1238 - 1244.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
R. A. Li, R. G. Tsushima, K. Himmeldirk, D. S. Dime, and P. H. Backx
Local Anesthetic Anchoring to Cardiac Sodium Channels : Implications Into Tissue-Selective Drug Targeting
Circ. Res., July 9, 1999; 85(1): 88 - 98.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. R. Balser
Structure and function of the cardiac sodium channels
Cardiovasc Res, May 1, 1999; 42(2): 327 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. C Makielski, J. Limberis, Z. Fan, and J. W Kyle
Intrinsic lidocaine affinity for Na channels expressed in Xenopus oocytes depends on {alpha} (hH1 vs. rSkM1) and {beta}1 subunits
Cardiovasc Res, May 1, 1999; 42(2): 503 - 509.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J.-F. Desaphy, A. De Luca, S. Pierno, P. Imbrici, and D. C. Camerino
Partial Recovery of Skeletal Muscle Sodium Channel Properties in Aged Rats Chronically Treated with Growth Hormone or the GH-Secretagogue Hexarelin
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 903 - 912.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. L. Sah, R. G. Tsushima, and P. H. Backx
Effects of local anesthetics on Na+ channels containing the equine hyperkalemic periodic paralysis mutation
Am J Physiol Cell Physiol, August 1, 1998; 275(2): C389 - C400.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Liu, R. B. Melchert, and R. H. Kennedy
Inhibition of L-Type Ca2+ Channel Current in Rat Ventricular Myocytes by Terfenadine
Circ. Res., August 19, 1997; 81(2): 202 - 210.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. De Luca, S. Pierno, F. Natuzzi, C. Franchini, A. Duranti, G. Lentini, V. Tortorella, H. Jockusch, and D. C. Camerino
Evaluation of the Antimyotonic Activity of Mexiletine and Some New Analogs on Sodium Currents of Single Muscle Fibers and on the Abnormal Excitability of the Myotonic ADR Mouse
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 93 - 100.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. W. Wang, K. Yazawa, A. L. George Jr., and P. B. Bennett
Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome
PNAS, November 12, 1996; 93(23): 13200 - 13205.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Biophysical Society.